Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
Analytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisEureka AI Inside
Professional Services
Customer Stories
Blog
Global Innovation Report
Glossary
Newsroom
Webinars & Training
Frontier
User Community
Trust and Security
PatentBench
LLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Analyse asundexian's oxopyridine scaffold, sub-nanomolar FXIa potency (Ki 0.26 nM), >38,000-fold selectivity over Factor Xa and thrombin, and structural differentiation from DOAC chemical series.
Article | Report DESTINY-Breast04 subgroup forest plot analysis: which HER2-low metastatic breast cancer patients derive the greatest OS benefit from T-DXd? Data-driven patient selection guide.
Article | Report Voclosporin vs cyclosporine A: structural modifications, SAR patterns, nephrotoxicity reduction data, ADME/PK profile, and pharmacophore features in IgA nephropathy.
Article | Report Deep-dive into Tarlatamab (AMG 757) BiTE architecture: DLL3-binding SAR, CD3 affinity tuning, bivalency data, and how it outperforms earlier DLL3 bispecifics.
Article | Report Deep patent analysis of tezepelumab: CDR sequences, epitope binding data, Fc engineering for half-life extension, and structural differentiation from earlier anti-TSLP biologics.
Article | Report How do Risdiplam and Branaplam differ from Nusinersen and Tofersen in CNS delivery, target engagement, and durability across SMA, ALS, and Huntington's disease?
Article | Report PLA, PHA, PBS, and cellulose derivatives vs. conventional plastics: patent trends, performance benchmarks, pricing, and market forecasts through 2030.
Article | Report Long-term DESTINY-Breast04 data show T-DXd cuts death risk by 31–42% vs TPC across HR+, HR−, and ER-subgroups in HER2-low metastatic breast cancer.
Article | Report How to engineer polymer composites with high thermal conductivity and electrical insulation for power electronics: filler selection, hybrid architectures, and breakdown voltage strategies.
Article | Report PEM, alkaline, and solid oxide electrolyzer critical materials in 2026: iridium scarcity, patent trends, and the innovation pipeline shaping green hydrogen at scale.
Article | Report Compare pure silicon, SiC composites, and SiOx anode materials across capacity, cycle life, and manufacturing readiness. Data-driven analysis for 2026 battery R&D.
Article | Report How to select and optimize polymer resin systems for low-dielectric 5G copper clad laminates. Dk/Df targets, filler design, and thermal stability strategies.
Article | Report Iptacopan and danicopan vs eculizumab and ravulizumab in PNH: mechanistic rationale for proximal vs terminal complement inhibition and EVH control evidence.
Article | Report How do sulfide, oxide, and polymer solid-state electrolytes compare in 2026? Ionic conductivity, stability, and patent trends analysed from 539 filings.
Article | Report How to formulate high-performance ceramide-based skin barrier repair creams: ingredient selection, concentration optimisation, emulsion stability, and efficacy validation.